Jips Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -2.81%
- Profit Growth 2477.53%
- Ebitda 270.55%
- Net Worth 29.03%
- Total Assets -60.16%
About Jips Pharmaceuticals
Jips Pharmaceuticals Private Limited (JPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 January 2017 (Eight years 16 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Supreet Singh, Jagdeep Singh, Parvinder Singh, and One other member serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24304CH2017PTC041344
- Company No.
041344
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Jips Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Supreet Singh  | Director | 17-Jan-2017 | Current |
| Jagdeep Singh | Director | 13-Jan-2017 | Current |
| Parvinder Singh | Director | 13-Jan-2017 | Current |
| Irvandeep Kaur | Director | 17-Jan-2017 | Current |
Financial Performance of Jips Pharmaceuticals.
Jips Pharmaceuticals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.81% decrease. The company also saw a substantial improvement in profitability, with a 2477.53% increase in profit. The company's net worth Soared by an impressive increase of 29.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jips Pharmaceuticals?
Unlock access to Jips Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Psychocare Health Private LimitedSupreet Singh and Jagdeep Singh are mutual person
Mind In Peace Private LimitedSupreet Singh and Jagdeep Singh are mutual person
- Kyracare Remedies Private Limited
Supreet Singh and Jagdeep Singh are mutual person
- Sehatokart Ventures Private Limited
Supreet Singh and Jagdeep Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jips Pharmaceuticals?
Jips Pharmaceuticals has a workforce of 40 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jips Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jips Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.